- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02196571
Structured Aerobic and Resistance Exercise and Gestational Diabetes
July 16, 2016 updated by: Iva Sklempe Kokic, Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse
The Impact of Structured Aerobic and Resistance Exercise on the Course and Outcome of Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is defined as impaired glucose tolerance of various degrees first manifested during pregnancy.
The primary aim of treating GDM is to optimize glycaemic control and improve pregnancy outcomes.
Also, as part of treatment, it is recommended to continue or initiate exercising with moderate intensity.
However, available data on the effects of physical activity on GDM are based on a small number of trials.
The aim of the trial is to examine and add new scientific evidence on possible health-related effects of application of structured programme consisting of aerobic and resistance exercises on the course and outcomes of GDM.
Primary goal of research is to determine how proposed exercise programme effects glycaemic control, rate of complications during pregnancy, labour, delivery, immediate after delivery and health status of newborn.
Main hypothesis is that parameters of glycaemic control, course of GDM, complications during delivery and birth outcomes directly and significantly correlate with participation in structured programme of exercise.
Research will be conducted as experimentally designed randomized controlled trial.
Participants will be pregnant women diagnosed with GDM, age between 20 and 40, without comorbidities.
Women in the experimental group will be included in exercise programme two times per week with duration of 50 minutes.
Training sessions will start right after the diagnosis and will be performed until the end of the pregnancy.
The training protocol will follow international guidelines (ACOG, 2001; ACOG, 2002; ADA, 2008; NICE, 2008; ADA 2011).
Women in the control group will receive standard medical care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zagreb, Croatia, 10000
- Association for functional rehabilitation, recreation and applied kinesiology Impuls
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- established diagnosis of gestational diabetes,
- age between 20 and 40,
- otherwise healthy pregnancy
Exclusion Criteria:
- pharmacological treatment with oral hypoglicemics and/or insulin therapy introduced prior to trial enrollment,
- existing comorbidities and
- contraindications for exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise and lifestyle change
Women in the experimental group will be included in structured exercise programme two times per week with duration of 50 minutes.Participants will start with training sessions right after they are diagnosed with GDM and they will exercise until the end of the pregnancy or occurence of contraindications.
Programme will consist of aerobic exercises (20 minutes), resistance exercises (20 minutes), plevic floor, stretching and relaxation exercises (10 minutes).
Women in control group will receive standard antenatal care.
|
|
|
No Intervention: Control
Standard antenatal care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of pregnant women with complications during pregnancy, labour and delivery
Time Frame: up to labour
|
Blood glucose levels, need for insulin and oral hypoglycemic drugs, need for cesarean section and other operative delivery methods, other adverse occurences during pregnancy, labour and delivery
|
up to labour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of macrosomic infants
Time Frame: delivery
|
delivery
|
|
|
Weight gain in pregnancy
Time Frame: After recruitment and during pregnancy (30, 33 and 36 weeks)
|
Body mass and percentage of fat measured by caliper
|
After recruitment and during pregnancy (30, 33 and 36 weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Low Back Pain
Time Frame: after recruitment and during pregnancy (30 and 36 weeks)
|
Visual analogue scale Roland-Morris Low Back Pain and Disability Questionnaire Pelvic Girdle Questionnaire
|
after recruitment and during pregnancy (30 and 36 weeks)
|
|
Physical Activity in Pregnancy
Time Frame: After recruitment and in 30th and 36th week of pregnancy
|
Pregnancy Physical Activity Questionnaire
|
After recruitment and in 30th and 36th week of pregnancy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Iva Sklempe Kokic, PT, PgD Kin, Association for functional rehabilitation, recreation and applied kinesiology Impuls
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
July 19, 2014
First Submitted That Met QC Criteria
July 21, 2014
First Posted (Estimate)
July 22, 2014
Study Record Updates
Last Update Posted (Estimate)
July 19, 2016
Last Update Submitted That Met QC Criteria
July 16, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Impuls001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes Mellitus
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Sonoma...CompletedType 2 Diabetes Mellitus | Gestational Diabetes MellitusUnited States
-
University of California, Los AngelesRecruitingGestational Diabetes Mellitus in PregnancyUnited States
-
i-Health, Inc.CompletedGestational Diabetes Mellitus in PregnancyGermany
-
The Danish Center for Strategic Research on Type...Odense University HospitalCompletedGestational Diabetes Mellitus in PregnancyDenmark
-
Services Institute of Medical Sciences, PakistanCompletedGestational Diabetes Mellitus in PregnancyPakistan
-
Danone Asia Pacific Holdings Pte, Ltd.Nutricia ResearchTerminatedGestational Diabetes Mellitus in PregnancySingapore
-
Federal State Budgetary Institution, V. A. Almazov...RecruitingGestational Diabetes Mellitus (GDM)Russian Federation
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
Clinical Trials on Structured Exercise
-
Hospital General de México Dr. Eduardo LiceagaNational Council of Science and Technology, Mexico; Universidad Nacional Autonoma... and other collaboratorsUnknownLiver Diseases | Obesity | Metabolic Syndrome | Exercise | Childhood Obesity | Cardiovascular Risk FactorMexico
-
Nova Scotia Health AuthorityTerminatedChronic Phase Stroke PatientsCanada
-
Maharishi Markendeswar University (Deemed to be...Recruiting
-
Istanbul UniversityMedipol University; Istanbul University - Cerrahpasa (IUC)Completed
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentCompleted
-
Weill Medical College of Cornell UniversityHospital for Special Surgery, New YorkCompletedPostoperative ComplicationsUnited States
-
Indonesia UniversityCompletedType 2 Diabetes Mellitus | Oxidative Stress | Resistance Training | Physical Fitness | High-Intensity Interval TrainingIndonesia
-
Hong Kong Baptist UniversityRecruitingDepressive SymptomsHong Kong
-
University Hospital, Basel, SwitzerlandTerminatedHeart Defects, CongenitalSwitzerland, Spain